Status:
RECRUITING
The Helios Heart Registry: A Standardized Registry for Patients With Specific Cardiac Diseases
Lead Sponsor:
Helios Health Institute GmbH
Conditions:
Heart Failure
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
Investigator-initiated, prospective, non-randomized, open label, non-interventional multicenter registry to evaluate current treatment of three major cardiovascular disease entities in clinical practi...
Detailed Description
Heart failure (HF), coronary artery disease (CAD) and atrial fibrillation (AF) are among the most relevant cardiovascular diseases contributing to overall morbidity and mortality each itself and in pa...
Eligibility Criteria
Inclusion
- Age of 18 years or older
- Inpatient Treatment
- Present diagnosis of at least one of the three cardiovascular disease entities of interest according to the current guidelines of the European Society of Cardiology (ESC): HF, CAD, AF
Exclusion
- Inability to provide informed consent
- Initial presentation (index hospitalization) in cardiogenic shock or other kinds of shock
- Patient after heart transplantation or patient with present ventricular assist device (VAD)
Key Trial Info
Start Date :
March 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
24000 Patients enrolled
Trial Details
Trial ID
NCT04844944
Start Date
March 30 2021
End Date
March 1 2026
Last Update
October 9 2024
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Helios Klinikum Berlin-Buch
Berlin, Germany, 13125
2
Helios Klinikum Erfurt
Erfurt, Germany, 99089
3
Helios Klinikum Gifhorn
Gifhorn, Germany, 38518
4
Helios Klinikum Hildesheim
Hildesheim, Germany, 31135